These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


330 related items for PubMed ID: 12796787

  • 1. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
    Ball LM, Lankester AC, Giordano PC, van Weel MH, Harteveld CL, Bredius RG, Smiers FJ, Egeler RM, Vossen JM.
    Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [Abstract] [Full Text] [Related]

  • 3. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
    La Nasa G, Argiolu F, Giardini C, Pession A, Fagioli F, Caocci G, Vacca A, De Stefano P, Piras E, Ledda A, Piroddi A, Littera R, Nesci S, Locatelli F.
    Ann N Y Acad Sci; 2005 Dec; 1054():186-95. PubMed ID: 16339665
    [Abstract] [Full Text] [Related]

  • 4. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D, Zecca M, Giorgiani G, Montagna D, Cristantielli R, Labirio M, Grignani P, Previderè C, Di Cesare-Merlone A, Amendola G, Bergami E, Mastronuzzi A, Maccario R, Locatelli F.
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [Abstract] [Full Text] [Related]

  • 5. Second marrow transplants for graft failure in patients with thalassemia.
    Gaziev D, Polchi P, Lucarelli G, Galimberti M, Sodani P, Angelucci E, Giardini C, Baronciani D, Erer B.
    Bone Marrow Transplant; 1999 Dec; 24(12):1299-306. PubMed ID: 10627638
    [Abstract] [Full Text] [Related]

  • 6. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
    Rosales F, Peylan-Ramu N, Cividalli G, Varadi G, Or R, Naparstek E, Slavin S, Nagler A.
    Bone Marrow Transplant; 1999 May; 23(9):861-5. PubMed ID: 10338039
    [Abstract] [Full Text] [Related]

  • 7. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ.
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow transplant cure for beta-thalassaemia major: initial experience from a developing country.
    Ullah K, Khan B, Raza S, Ahmed P, Satti TM, Butt T, Tariq WZ, Kamal MK.
    Ann Hematol; 2008 Aug; 87(8):655-61. PubMed ID: 18458905
    [Abstract] [Full Text] [Related]

  • 9. Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
    Li CK, Shing MM, Chik KW, Lee V, Tsang KS, Yuen PM.
    Pediatr Hematol Oncol; 2002 Jun; 19(4):267-71. PubMed ID: 12051594
    [Abstract] [Full Text] [Related]

  • 10. Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens.
    Bleyzac N, Souillet G, Magron P, Janoly A, Martin P, Bertrand Y, Galambrun C, Dai Q, Maire P, Jelliffe RW, Aulagner G.
    Bone Marrow Transplant; 2001 Oct; 28(8):743-51. PubMed ID: 11781625
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning.
    Zaretsky Y, Rifkind J, Lockwood G, Tsang R, Kiss T, Hasegawa W, Fyles G, Tejpar I, Loach D, Minden M, Messner H, Lipton JH.
    Bone Marrow Transplant; 2007 Sep; 40(5):423-30. PubMed ID: 17603516
    [Abstract] [Full Text] [Related]

  • 12. Haematopoietic stem cell transplantation for thalassaemia major in Hong Kong: prognostic factors and outcome.
    Li CK, Shing MM, Chik KW, Lee V, Leung TF, Cheung AY, Yuen MP.
    Bone Marrow Transplant; 2002 Jan; 29(2):101-5. PubMed ID: 11850702
    [Abstract] [Full Text] [Related]

  • 13. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G.
    Ann N Y Acad Sci; 2005 Jul; 1054():196-205. PubMed ID: 16339666
    [Abstract] [Full Text] [Related]

  • 15. Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience.
    Zwaan CM, Van Weel-Sipman MH, Fibbe WE, Oudshoorn M, Vossen JM.
    Bone Marrow Transplant; 1998 Mar; 21(5):447-53. PubMed ID: 9535036
    [Abstract] [Full Text] [Related]

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 17. Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.
    Sauer M, Bettoni C, Lauten M, Ghosh A, Rehe K, Grigull L, Beilken A, Welte K, Sykora KW.
    Bone Marrow Transplant; 2005 Sep; 36(5):383-7. PubMed ID: 15995711
    [Abstract] [Full Text] [Related]

  • 18. Bone marrow transplantation for thalassaemia: experience of two British centres.
    Vellodi A, Picton S, Downie CJ, Eltumi M, Stevens R, Evans DI.
    Bone Marrow Transplant; 1994 May; 13(5):559-62. PubMed ID: 8054908
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L, Ladeb S, Ben Othman T, Abdelkefi A, Lakhal A, Ben Abdeladhim A.
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow transplantation for thalassemia. Experience in Pesaro, Italy.
    Giardini C, Angelucci E, Lucarelli G, Galimberti M, Polchi P, Baronciani D, Bechelli G.
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):6-10. PubMed ID: 8311174
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.